Table 2.
Thrombolytic procedure according to aetiology of arterial occlusion
| All procedures (n = 749) | Acute arterial thrombosis (n = 232) | Embolus (n = 161) | Popliteal aneurysm (n = 48) | Graft occlusion (n = 280) | P† | |
|---|---|---|---|---|---|---|
| Continuous heparin infusion | 473 (63·2) | 140 (60·3) | 79 (49·1)* | 26 (54) | 215 (76·8)* | <0.001 |
| Mean rtPA dose (mg) | 21·0 | 20·2 | 18·6 | 25·5* | 22·6 | <0.001 |
| Mean duration of thrombolysis (h) | 25·2 | 25·4 | 23·1 | 28·0 | 26·3 | 0.056 |
| Successful lysis | 601 (80·2) | 179 (77·2) | 131 (81·4) | 34 (71) | 241 (86·1)* | 0.017 |
Values in parentheses are percentages of all procedures or of the relevant aetiological group. rtPA, recombinant tissue plasminogen activator.
*
P <0·010 versus other groups;
†
comparisons of all groups (cross-tabulation with χ2 test for dichotomous variables and one-way ANOVA for continuous variables).